Ovarian Cancer and Female Health
A special issue of International Journal of Environmental Research and Public Health (ISSN 1660-4601). This special issue belongs to the section "Health Behavior, Chronic Disease and Health Promotion".
Deadline for manuscript submissions: closed (30 September 2021) | Viewed by 2451
Special Issue Editors
Interests: cytoreductive surgery; ovarian cancer; surgery; peritoneal metastases
Special Issue Information
Dear Colleagues,
Ovarian Cancer is the deadliest of all gynecologic malignancies, despite significant advances in surgical techniques, chemotherapeutic options, and supportive care during the last few decades.
In the early stages, it often remains asymptomatic because of the anatomic location of the ovaries deep in the pelvis. Standard management of patients with tumor localized to the ovary(ies) includes comprehensive surgical staging in order to provide guidance for a subsequent need for adjuvant treatment. The extent of residual disease after radical surgical cytoreduction represents a significant predictor for progression-free and overall survival.
Hyperthermic intraperitoneal chemotherapy has shown significant survival benefits over standard systemic intravenous chemotherapy in metastatic disease that has been optimally debulked, in the primary, interval, or recurrent setting.
This invitation aims to reach out to surgical and gynecologic oncologists treating patients with cytoreductive surgery, interval debulking, systemic (neoadjuvant/adjuvant), and hyperthermic intraperitoneal chemotherapy, as well as molecular targeted and immunologically active agents.
Subjects such as fertility-sparing surgery, multidisciplinary surgical approaches, perioperative staging and re-staging systems, patient selection processes for active treatment options or palliation, peritonectomy procedures, indications for lymph node resection, management of recurrent disease, molecular targets, immunotherapy, genetic counseling, and the use of hyperthermic intraperitoneal chemotherapy (HIPEC) are kindly requested for submission.
The scope of this Thematic Issue is to bring attention to recent advances in the management algorithm of ovarian cancer patients during the different stages of the disease, in order to promote the conversion of a lethal disease into a chronic disease.
Dr. Evgenia Halkia
Prof. Dr. Jesus Esquivel
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Environmental Research and Public Health is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2500 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- ovarian cancer
- fertility-sparing surgery
- peritoneal metastases
- cytoreductive surgery
- debulking surgery
- systemic chemotherapy
- ovarian cancer targeted therapy
- hyperthermic intraperitoneal chemotherapy
- peritonectomy procedures
- peritoneal carcinomatosis
- adnexal mass
- hepatic metastases in ovarian cancer
- ovarian cancer peritoneal carcinomatosis
- malignant ascites
